CONSTRUCTION OF 2-THIOXOQUINAZOLIN-4(3H)-ONE DERIVATIVE THROUGH CYCLIZATION OF ANTHRANILIC ACID WITH 4-CHLOROPHENYL ISOTHIOCYANATE
Zulpanov F. A., Otamurodov M. R., Khudoyberdiyeva O. O., Yakubov U. M. & Elmuradov B. J.
Annotatsiya
By synthesizing compounds containing various functional groups within the heterocyclic structure, optimal reaction conditions were proposed. To optimize the reaction parameters, a series of experiments were carried out, in which factors such as the type of solvent (DMF, DMSO), the nature of the main heterocyclizing reagent (4-chlorphenyl isothyocyanate), temperature, and reaction time were studied. Among the synthesized compounds, promising samples with high biological activity were identified. It was established that the proposed synthesis method is relatively simple and cost-effective.
Adabiyotlar
- Mikra C., Bairaktari M., petridi M., Detsi A. Issue 10. 2022. 20-21 p. doi.org 10.3390 p.
- Wang S.B., Deng X.Q., Zheng Y., Yuan Y.P., Quan Z.S., Guan L.P. Synthesis and evaluation of anticonvulsant and antidepressant activities of 5alkoxytetrazolo[1,5-c]thieno[2,3e]pyrimidine derivatives. European journal of medicinal chemistry. 2012;56:139-144 p.
- Sordella R., Bell D.W., Haber D.A. and Settleman J. Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways. Science. - 2004. -Vol. 305. - 1163-1167 p.
- Cohen M.H., Johnson J.R., Chen Y.F., Sridhara R., Pazdur R. (2005) FDA drug approval summary: erlotinib (Tarceva) tablets. Oncologist; 10:461–466 p.
- Pawan K., Premnath D., Muhammad T., Mazlee S., Yaman M., Nurul S., Muhammad S. et al. A controlled, efficient and robust process for the synthesis of an epidermal growth factor receptor inhibitor: Afatinib Dimaleate. February 4, 2019. 5-105-106 p. DOI:10.25082/CR.2019.01.001
- Petrov K.G., Zhang Y.M., Carter M., Cockerill G.S., Dickerson S., Gauthier C.A., Guo Y., Mook R.A. Jr, Rusnak D.W., Walker A.L., Wood E.R., Lackey K.E. (2006) ErbB-2 tyrosine kinase inhibition in the 6-furanylquinazoline series. Bioorg Med Chem Lett; 16:4686–4691.
- Wu X., Li M., Tang W., Zheng Y., Lian J., Xu L., Ji M. Design Synthesis and In vitro Antitumor Activity Evaluation of Novel 4-pyrrylamino Quinazoline Derivatives. Chemical biology & drug design. 2011;78(6):932-940 p.
- Singh K, Sharma P, Kumar A, Chaudhary A, Roy R. 4Aminoquinazoline Analogs: A Novel Class of Anticancer Agents. Mini reviews in medicinal chemistry. 2013;13(8):1177-1194
- Marzaro G, Guiotto A, Chilin A. Quinazoline derivatives as potential anticancer agents: a patent review (2007-2010). Expert opinion on therapeutic patents. 2012;22-23 p.